{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:34:11Z","timestamp":1789932851949,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jacl.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T08:30:44Z","timestamp":1534235444000},"page":"1532-1538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-4947","authenticated-orcid":false,"given":"Felipe","family":"Vendrame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Olops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Teresinha Olalla","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Yotsumoto","family":"Fertrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0046-8177(71)80023-0","article-title":"Serum lipid precursors of coronary heart disease","volume":"2","author":"Kannel","year":"1971","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","article-title":"Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study","volume":"90","author":"Kannel","year":"1979","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0268-960X(03)00003-1","article-title":"The paradox of hemoglobin SC disease","volume":"17","author":"Nagel","year":"2003","journal-title":"Blood Rev"},{"issue":"9757","key":"10.1016\/j.jacl.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"7517","key":"10.1016\/j.jacl.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(67)90685-X","article-title":"Hypolipidaemia in anaemia. Implications for the epidemiology of ischaemic heart-disease","volume":"2","author":"Rifkind","year":"1967","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1975.tb00835.x","article-title":"Hypocholesterolaemia and anaemia","volume":"31","author":"Westerman","year":"1975","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2257.1983.tb00494.x","article-title":"Plasma and erythrocyte lipids in sickle cell anaemia","volume":"5","author":"Sasaki","year":"1983","journal-title":"Clin Lab Haematol"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2141.2010.08109.x","article-title":"Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension","volume":"149","author":"Zorca","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jacl.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1179\/1607845414Y.0000000171","article-title":"Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease","volume":"20","author":"Ataga","year":"2015","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12944-017-0454-1","article-title":"Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia","volume":"16","author":"Aleluia","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jacl.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/13294","article-title":"Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains","volume":"6","author":"Paoli","year":"1999","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jacl.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fphys.2015.00011","article-title":"A1M\/alpha1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation","volume":"6","author":"Cederlund","year":"2015","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jacl.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1006\/bbrc.2002.6540","article-title":"The atomic structure of human methemalbumin at 1.9 A","volume":"291","author":"Wardell","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2012.00077","article-title":"Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases","volume":"3","author":"Larsen","year":"2012","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jacl.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-2275(20)32564-5","article-title":"Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages","volume":"39","author":"Camejo","year":"1998","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.jacl.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/ATVBAHA.110.206433","article-title":"Red cells, hemoglobin, heme, iron, and atherogenesis","volume":"30","author":"Nagy","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fphys.2014.00379","article-title":"Red blood cell, hemoglobin and heme in the progression of atherosclerosis","volume":"5","author":"Jeney","year":"2014","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.jacl.2018.08.002_bib19","first-page":"813","article-title":"Reduced cholesterol levels in African-American adults with sickle cell disease","volume":"95","author":"Shores","year":"2003","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjh.12342","article-title":"Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease","volume":"162","author":"Wang","year":"2013","journal-title":"Br J Haematol"},{"issue":"9442","key":"10.1016\/j.jacl.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jacl.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.clinbiochem.2009.06.024","article-title":"Hemoglobin disorders and endothelial cell interactions","volume":"42","author":"Conran","year":"2009","journal-title":"Clin Biochem"},{"issue":"9","key":"10.1016\/j.jacl.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.clinbiochem.2013.01.007","article-title":"Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions","volume":"46","author":"Gaal","year":"2013","journal-title":"Clin Biochem"},{"issue":"25","key":"10.1016\/j.jacl.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.jacl.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"1-2","key":"10.1016\/j.jacl.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0003-2697(75)90488-1","article-title":"Separation of plasma lipoproteins by density-gradient ultracentrifugation","volume":"65","author":"Redgrave","year":"1975","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"1532832","DOI":"10.1155\/2016\/1532832","article-title":"The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis","volume":"2016","author":"Roshan","year":"2016","journal-title":"Int J Inflamm"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.20804","article-title":"Hypocholesterolemia in chronic anemias with increased erythropoietic activity","volume":"82","author":"Shalev","year":"2007","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.11613\/BM.2011.015","article-title":"Effects of hemolysis interferences on routine biochemistry parameters","volume":"21","author":"Koseoglu","year":"2011","journal-title":"Biochem Med"},{"issue":"1","key":"10.1016\/j.jacl.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2003-08-2760","article-title":"Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease","volume":"104","author":"Jison","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jacl.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacl.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphar.2014.00115","article-title":"Heme on innate immunity and inflammation","volume":"5","author":"Dutra","year":"2014","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jacl.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jacl.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood.V95.11.3442","article-title":"Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants","volume":"95","author":"Balla","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jacl.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4439(99)00027-7","article-title":"Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation","volume":"1454","author":"Miller","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","article-title":"Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation","volume":"34","author":"Badrnya","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"10.1016\/j.jacl.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jacl.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12265-012-9426-z","article-title":"Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem","volume":"6","author":"Chacko","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.jacl.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1074\/mcp.M113.028134","article-title":"Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies","volume":"12","author":"Gordon","year":"2013","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"10.1016\/j.jacl.2018.08.002_bib44","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.jacl.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"e34107","DOI":"10.1371\/journal.pone.0034107","article-title":"HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach","volume":"7","author":"Mange","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jacl.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.jacl.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1021\/pr100520x","article-title":"Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography","volume":"9","author":"Gordon","year":"2010","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.jacl.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvu147","article-title":"HDL-mediated mechanisms of protection in cardiovascular disease","volume":"103","author":"Kontush","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.jacl.2018.08.002_bib50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/1535370217706966","article-title":"Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients","volume":"241","author":"Soupene","year":"2017","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:41:20Z","timestamp":1661751680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418303581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1933287418303581"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.08.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}